Found 19 results for Breast Cancer
A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
SHORTER ANTHRACYCLINE-FREE CHEMO IMMUNOTHERAPY ADAPTED TOPATHOLOGICAL RESPONSE IN EARLY TRIPLE NEGATIVE BREAST CANCER (SCARLET), ARANDOMIZED PHASE III STUDY
K
Kathy Miller, MD
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in …
Randomized, Open-Label Study of the Bria-Imt Regimen and Check Point Inhibitor Vs Physician S Choice in Advanced Metastatic Breast Cancer (Bria-Abc)
T
Tarah Ballinger, MD
The purpose of this study is to evaluate the effect of the Bria-IMT regimen in combination with Check Point Inhibitor (CPI) on overall survival (OS) compared to treatment of physician’s choice (TPC) chemotherapy in patients with metastatic breast cancer with no approved alternative therapies available as per the Inclusion criter …
Breast Cancer Survivors and Their Partners Needed for Research Study!
R
Rosie Shrout
ARE YOU OR SOMEONE YOU KNOW A BREAST CANCER SURVIVOR?; We need your help!Researchers at Purdue University are exploring how relationships and stress affect couples' immune and cardiovascular systems during breast cancer survivorship.You may be eligible to participate if:You are 18 years or older.You or your partner had breast cancer …
A Phase Ii Single-Arm Pilot Study of Hydroxychloroquine for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (Aimss)
T
Tarah Ballinger, MD
The purpose of this study is to evaluate the effectiveness of hydroxychloroquine sulfate (a type of drug commonly used to treat joint pain caused by inflammation, swelling) in reducing joint pain associated with Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) for patients with breast cancer.Interested in participating? For more information about …
Translational Breast Cancer Research Consortium Biospecimen & Outcomes Repository
K
Kathy Miller, MD
The purpose of this study is to develop a repository of clinical data and outcomes, with and without corresponding specimens from individuals who have participated in TBCRC studies.
Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer Care THRIVE NOW in Obesity-Cancer Care
M
Misty Hawkins
There are long-standing inequities in interventions for obesity among Black Breast Cancer Survivors (BCS). While the American Cancer Society provides recommendations regarding weight management for successful cancer survivorship, the guidelines are not specific to women or Blacks. This 3-phase pilot study will address these inequities by inviting Black BCS with …
Developing Interventions to Support the Management of Oral Anticancer Medications in Patients with Breast Cancer
K
Kathy Miller, MD
The study aims to develop an early prototype intervention to support patients diagnosed with breast cancer who are receiving orally administered anticancer medication. In a previously approved pilot work, the study team identified design requirements and developed preliminary design concepts to address barriers related to the use of oral anticancer …
Fear of Cancer Occurrence: Development and Initial Psychometric Testing of a Fear Measure for Breast Cancer Previvors
S
Shelley Johns
To develop a measure of cancer-related fear in previvors, women with an increased risk of developing breast cancer within their lifetime but have never had a cancer diagnosis. Two existing fear measures will be used to develop the initial fear of cancer occurrence (FOCO) measure, then two rounds of cognitive …
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
J
Jonathan L. Berkowitz, MD, PhD
This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual …
11 - 19 of 19
- 1
- 2
Please choose between Voice or SMS based delivery of verification code
or